Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 11-2020 | 11-2019 | 11-2018 | 11-2017 | 11-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,361 | 6,541 | 6,040 | 6,279 | 3,500 |
| Marketable Securities | 89 | 904 | 876 | 439 | 624 |
| Receivables | 6,323 | 6,097 | 5,867 | 5,126 | 4,053 |
| Inventories | 927 | 1,085 | 1,261 | 315 | 361 |
| Other current assets | 245 | 260 | 255 | 206 | 79 |
| TOTAL | $18,556 | $15,388 | $14,760 | $12,737 | $9,012 |
| Non-Current Assets | |||||
| PPE Net | 1,641 | 1,847 | 1,493 | 882 | 980 |
| Investments And Advances | 308 | 308 | 308 | 0 | 0 |
| Intangibles | 3,473 | 3,191 | 3,283 | 226 | 261 |
| Other Non-Current Assets | 22,222 | 22,153 | 22,546 | 10,064 | 9,286 |
| TOTAL | $27,644 | $27,499 | $27,630 | $11,173 | $10,527 |
| Total Assets | $46,200 | $42,886 | $42,390 | $23,910 | $19,539 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 957 | 1,369 | 1,262 | 1,929 | 1,485 |
| Accrued Expenses | 2,898 | 2,085 | 2,703 | 2,583 | 2,554 |
| TOTAL | $16,415 | $15,429 | $15,430 | $13,940 | $13,112 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,841 | 5,856 | 9,844 | 5,295 | 7,820 |
| Deferred Revenues | 9,184 | 8,875 | 8,365 | 7,429 | 7,072 |
| Other Non-Current Liabilities | 2,409 | 4,920 | 5,708 | 1,425 | 1,425 |
| TOTAL | $32,451 | $34,410 | $35,869 | $22,473 | $21,841 |
| Total Liabilities | $48,865 | $49,839 | $51,298 | $36,413 | $34,953 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,571 | 7,546 | 7,803 | 7,105 | 7,140 |
| Common Shares | 136 | 136 | 136 | 129 | 125 |
| Retained earnings | -18,820 | -22,444 | -25,330 | -24,475 | -26,790 |
| Other shareholders' equity | 437 | 437 | 770 | 470 | -90 |
| TOTAL | $-2,665 | $-6,953 | $-8,908 | $-12,503 | $-15,414 |
| Total Liabilities And Equity | $46,200 | $42,886 | $42,390 | $23,910 | $19,538 |